Statera Biopharma, Inc. Accounts Payable
Statera Biopharma, Inc. had Accounts Payable of $8.13 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2022-11-14
- 2022-09-30: Accounts Payable, Current $8.13M.
- 2022-06-30: Accounts Payable, Current $8.07M.
- 2022-03-31: Accounts Payable, Current $6.74M.
- 2021-12-31: Accounts Payable, Current $3.96M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2022-09-30 | $8.13M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $8.07M 10-Q · filed 2022-10-28 | |
| 2022-03-31 | $6.74M 10-Q · filed 2022-10-21 | |
| 2021-12-31 | $3.96M 10-Q · filed 2022-11-14 | |
| 2021-09-30 | $3.19M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $60.50K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $309.72K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.13M 10-K · filed 2022-10-06 | $167.77K 10-K · filed 2021-03-22 |
| 2020-09-30 | $280.56K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $301.62K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $266.06K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $263.57K 10-K · filed 2021-03-22 | |
| 2019-09-30 | $99.53K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $274.90K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $245.25K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $139.12K 10-K · filed 2020-04-15 | |
| 2018-09-30 | $120.46K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $151.89K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $267.95K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $201.40K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $380.91K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $298.28K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $379.21K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $336.44K 10-K · filed 2018-03-06 | |
| 2016-09-30 | $186.86K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $144.17K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $246.49K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $197.13K 10-K · filed 2017-02-22 | |
| 2015-09-30 | $623.29K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $950.43K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $989.65K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.06M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $889.40K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $719.64K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $489.44K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $794.40K 10-K · filed 2015-02-27 | |
| 2013-09-30 | $1.20M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $1.19M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $1.23M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $1.52M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $440.52K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $671.39K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $1.07M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $909.14K 10-K · filed 2013-03-18 | |
| 2011-09-30 | $1.33M 10-Q/A · filed 2011-11-14 | |
| 2011-06-30 | $655.18K 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $1.26M 10-K · filed 2012-03-13 |